During the past decade, Cincinnati MDRU conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cincinnati MDRU" #1 collaborator was "Cincinnati MDRU" with 6 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cincinnati MDRU" are "Cocaine-Related Disorders" (6 trials), "Substance-Related Disorders" (3 trials) and "Opioid-Related Disorders" (2 trials). Many other conditions were trialed in "Cincinnati MDRU" in a lesser frequency.

Most popular intervention types in "Cincinnati MDRU" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Methylphenidate" (3 trials), "Buprenorphine" (1 trials), "Buprenorphine/naloxone" (1 trials), "Lamotrigine" (1 trials) and "Naltrexone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cincinnati MDRU" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Cincinnati MDRU". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Cincinnati MDRU, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cincinnati MDRU, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".